Skip to search formSkip to main contentSkip to account menu

Neulasta

National Institutes of Health

Related topics

Related topics

2 relations
0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe [Neulasta]

Broader (1)

pegfilgrastim

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract P4-12-07: Cost-minimization of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar ZARXIO® over NEUPOGEN®, NEULASTA®, and NEULASTA/ONPRO®: Breast cancer case study
RATIONALE & OBJECTIVES: Biosimilar filgrastim may offer significant cost advantages over originator filgrastim and pegfilgrastim… 
2017
2017
Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta ® in the prophylactic treatment of chemotherapy-induced neutropenia
2017
2017
Abstract P5-11-07: Pharmacokinetics of eflapegrastim in a phase 2 open-label dose-ranging study in breast cancer patients receiving TC regimen
Background: Eflapegrastim (SPI-2012/HM10460A) is a novel, long acting recombinant human granulocyte colony-stimulating factor… 
2017
2017
Abstract P5-11-08: Immunogenicity of eflapegrastim in a phase 2 open-label dose-ranging study of eflapegrastim in breast cancer patients receiving TC regimen
Background : Eflapegrastim (SPI-2012/HM10460A) is a novel, long-acting recombinant human granulocyte colony-stimulating factor… 
Review
2013
Review
2013
Hyperleukocytosis Caused By Neulasta Complicated By Leukostasis Versus Asymptomatic Uncomplicated Hyperleukocytosis In AML. Two Cases and When To Leukapherese
We describe two cases of hyperleukocytosis, one resulting from growth factor use with complications and the other a case of… 
2006
2006
Intensive Timed Sequential Chemotherapy Followed by a Single Pegfilgrastim (Neulasta) Administration in Patients with High-Risk Acute Myeloid Leukemia (AML): Preliminary Results of the EMA-2000/Neu…
Following a dose-escalation study performed in order to assess the maximally tolerated dose of high-dose mitoxantrone in a single… 
2005
2005
A phase II randomized study to compare the neoadjuvant dose dense administration of docetaxel (D) and vinorelbine (V) or D followed by doxorubicin (A) and cyclophosphamide (C) administered to women…
776 Background: Previously we demonstrated that a combination of docetaxel (D) (60 mg/m2) and vinorelbine (V) (45 mg/m2) (TN… 
2004
2004
Long-Term Safety and Efficacy of Single Administration of a Fixed Dose Pegfilgrastim (Neulasta) in Inducing Neutrophil Count Recovery after ABVD Chemotherapy in Patients with Hodgkin Lymphoma.
Pegfilgrastim (Neulasta) is a pegylated form of G-CSF that has a long half-life allowing for a single administration per… 
Review
2004
Review
2004
Pegfilgrastim (Neulasta®) and Filgrastim (Neupogen®) Use in Patients Receiving Chemotherapy in Oncology Practices: Interim Results of the Assessment of Current CSF Evaluation for Proper Therapy…
Introduction: The pivotal trials of pegfilgrastim and filgrastim demonstrated their value as primary protection if initiated 24… 
2004
2004
Pegfilgrastim (neulasta™) following chemotherapy leads to successful mobilization of hematopoietic progenitor cells among transplant patients with various diagnoses
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)